Selected research
Market Outlook & Growth Opportunities
Global RNA Sample Preservation Solution Market Outlook and Growth Opportunities 2026
Market perspective
The global RNA Sample Preservation Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for RNA Sample Preservation Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for RNA Sample Preservation Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for RNA Sample Preservation Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the RNA Sample Preservation Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the RNA Sample Preservation Solution market include Aptaca, BD, BIOBASE, BioServUK, Biosigma, Cardinal Health, Copan Diagnostics, EKF Diagnostics Holdings and Longhorn Vaccines and Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global RNA Sample Preservation Solution market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of RNA Sample Preservation Solution and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents RNA Sample Preservation Solution sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the RNA Sample Preservation Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
RNA Sample Preservation Solution Segment by Company
Aptaca
BD
BIOBASE
BioServUK
Biosigma
Cardinal Health
Copan Diagnostics
EKF Diagnostics Holdings
Longhorn Vaccines and Diagnostics
Medline Industries
Puritan Medical Products
Beijing Hanbaihan Medical
Darui Biotech
Orient Gene
Biocomma
Guangdong Hybribio Biotech
Longsee Biomedical
Haimen Shengbang Laboratory Equipment
Hangzhou Jiuyang Biotechnology
Hangzhou LifeReal Biotechnology
Jifan Biotechnology (Beijing)
Mole Bioscience
Thermo Fisher Scientific
Shandong Chengwu Medical Products Factory
RNA Sample Preservation Solution Segment by Type
Inactivated
Non-inactivated
RNA Sample Preservation Solution Segment by Application
Hospital
Clinic
Others
RNA Sample Preservation Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global RNA Sample Preservation Solution status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions RNA Sample Preservation Solution market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify RNA Sample Preservation Solution significant trends, drivers, influence factors in global and regions.
6. To analyze RNA Sample Preservation Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Sample Preservation Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of RNA Sample Preservation Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Sample Preservation Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the RNA Sample Preservation Solution market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RNA Sample Preservation Solution industry.
Chapter 3: Detailed analysis of RNA Sample Preservation Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of RNA Sample Preservation Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of RNA Sample Preservation Solution in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. RNA Sample Preservation Solution Industry Trends
Table 2. RNA Sample Preservation Solution Industry Drivers
Table 3. RNA Sample Preservation Solution Industry Opportunities and Challenges
Table 4. RNA Sample Preservation Solution Industry Restraints
Table 5. Global RNA Sample Preservation Solution Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global RNA Sample Preservation Solution Revenue Share by Company (2021-2026)
Table 7. Global RNA Sample Preservation Solution Sales Volume by Company (k units) & (2021-2026)
Table 8. Global RNA Sample Preservation Solution Sales Volume Share by Company (2021-2026)
Table 9. Global RNA Sample Preservation Solution Average Price (USD/unit) of Company (2021-2026)
Table 10. Global RNA Sample Preservation Solution Company Ranking, (2024-2026) & (USD Million)
Table 11. Global RNA Sample Preservation Solution Key Company Manufacturing Base & Headquarters
Table 12. Global RNA Sample Preservation Solution Company, Product Type & Application
Table 13. Global RNA Sample Preservation Solution Company Establishment Date
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global RNA Sample Preservation Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Significant Companies of Inactivated
Table 18. Significant Companies of Non-inactivated
Table 19. Global RNA Sample Preservation Solution Sales Volume by Type 2021 VS 2025 VS 2032 (k units)
Table 20. Global RNA Sample Preservation Solution Sales Volume by Type (2021-2026) & (k units)
Table 21. Global RNA Sample Preservation Solution Sales Volume by Type (2027-2032) & (k units)
Table 22. Global RNA Sample Preservation Solution Sales Volume Share by Type (2021-2026)
Table 23. Global RNA Sample Preservation Solution Sales Volume Share by Type (2027-2032)
Table 24. Global RNA Sample Preservation Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global RNA Sample Preservation Solution Sales Value by Type (2021-2026) & (US$ Million)
Table 26. Global RNA Sample Preservation Solution Sales Value by Type (2027-2032) & (US$ Million)
Table 27. Global RNA Sample Preservation Solution Sales Value Share by Type (2021-2026)
Table 28. Global RNA Sample Preservation Solution Sales Value Share by Type (2027-2032)
Table 29. Significant Companies of Hospital
Table 30. Significant Companies of Clinic
Table 31. Significant Companies of Others
Table 32. Global RNA Sample Preservation Solution Sales Volume by Application 2021 VS 2025 VS 2032 (k units)
Table 33. Global RNA Sample Preservation Solution Sales Volume by Application (2021-2026) & (k units)
Table 34. Global RNA Sample Preservation Solution Sales Volume by Application (2027-2032) & (k units)
Table 35. Global RNA Sample Preservation Solution Sales Volume Share by Application (2021-2026)
Table 36. Global RNA Sample Preservation Solution Sales Volume Share by Application (2027-2032)
Table 37. Global RNA Sample Preservation Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global RNA Sample Preservation Solution Sales Value by Application (2021-2026) & (US$ Million)
Table 39. Global RNA Sample Preservation Solution Sales Value by Application (2027-2032) & (US$ Million)
Table 40. Global RNA Sample Preservation Solution Sales Value Share by Application (2021-2026)
Table 41. Global RNA Sample Preservation Solution Sales Value Share by Application (2027-2032)
Table 42. Global RNA Sample Preservation Solution Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 43. Global RNA Sample Preservation Solution Sales by Region (2021-2026) & (k units)
Table 44. Global RNA Sample Preservation Solution Sales Market Share by Region (2021-2026)
Table 45. Global RNA Sample Preservation Solution Sales by Region (2027-2032) & (k units)
Table 46. Global RNA Sample Preservation Solution Sales Market Share by Region (2027-2032)
Table 47. Global RNA Sample Preservation Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 48. Global RNA Sample Preservation Solution Sales Value by Region (2021-2026) & (US$ Million)
Table 49. Global RNA Sample Preservation Solution Sales Value Share by Region (2021-2026)
Table 50. Global RNA Sample Preservation Solution Sales Value by Region (2027-2032) & (US$ Million)
Table 51. Global RNA Sample Preservation Solution Sales Value Share by Region (2027-2032)
Table 52. Global RNA Sample Preservation Solution Market Average Price (USD/unit) by Region (2021-2026)
Table 53. Global RNA Sample Preservation Solution Market Average Price (USD/unit) by Region (2027-2032)
Table 54. Global RNA Sample Preservation Solution Sales by Country: 2021 VS 2025 VS 2032 (k units)
Table 55. Global RNA Sample Preservation Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 56. Global RNA Sample Preservation Solution Sales by Country (2021-2026) & (k units)
Table 57. Global RNA Sample Preservation Solution Sales Market Share by Country (2021-2026)
Table 58. Global RNA Sample Preservation Solution Sales by Country (2027-2032) & (k units)
Table 59. Global RNA Sample Preservation Solution Sales Market Share by Country (2027-2032)
Table 60. Global RNA Sample Preservation Solution Sales Value by Country (2021-2026) & (US$ Million)
Table 61. Global RNA Sample Preservation Solution Sales Value Market Share by Country (2021-2026)
Table 62. Global RNA Sample Preservation Solution Sales Value by Country (2027-2032) & (US$ Million)
Table 63. Global RNA Sample Preservation Solution Sales Value Market Share by Country (2027-2032)
Table 64. Aptaca Company Information
Table 65. Aptaca Business Overview
Table 66. Aptaca RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 67. Aptaca RNA Sample Preservation Solution Product Portfolio
Table 68. Aptaca Recent Development
Table 69. BD Company Information
Table 70. BD Business Overview
Table 71. BD RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 72. BD RNA Sample Preservation Solution Product Portfolio
Table 73. BD Recent Development
Table 74. BIOBASE Company Information
Table 75. BIOBASE Business Overview
Table 76. BIOBASE RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 77. BIOBASE RNA Sample Preservation Solution Product Portfolio
Table 78. BIOBASE Recent Development
Table 79. BioServUK Company Information
Table 80. BioServUK Business Overview
Table 81. BioServUK RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 82. BioServUK RNA Sample Preservation Solution Product Portfolio
Table 83. BioServUK Recent Development
Table 84. Biosigma Company Information
Table 85. Biosigma Business Overview
Table 86. Biosigma RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 87. Biosigma RNA Sample Preservation Solution Product Portfolio
Table 88. Biosigma Recent Development
Table 89. Cardinal Health Company Information
Table 90. Cardinal Health Business Overview
Table 91. Cardinal Health RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 92. Cardinal Health RNA Sample Preservation Solution Product Portfolio
Table 93. Cardinal Health Recent Development
Table 94. Copan Diagnostics Company Information
Table 95. Copan Diagnostics Business Overview
Table 96. Copan Diagnostics RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 97. Copan Diagnostics RNA Sample Preservation Solution Product Portfolio
Table 98. Copan Diagnostics Recent Development
Table 99. EKF Diagnostics Holdings Company Information
Table 100. EKF Diagnostics Holdings Business Overview
Table 101. EKF Diagnostics Holdings RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 102. EKF Diagnostics Holdings RNA Sample Preservation Solution Product Portfolio
Table 103. EKF Diagnostics Holdings Recent Development
Table 104. Longhorn Vaccines and Diagnostics Company Information
Table 105. Longhorn Vaccines and Diagnostics Business Overview
Table 106. Longhorn Vaccines and Diagnostics RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 107. Longhorn Vaccines and Diagnostics RNA Sample Preservation Solution Product Portfolio
Table 108. Longhorn Vaccines and Diagnostics Recent Development
Table 109. Medline Industries Company Information
Table 110. Medline Industries Business Overview
Table 111. Medline Industries RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 112. Medline Industries RNA Sample Preservation Solution Product Portfolio
Table 113. Medline Industries Recent Development
Table 114. Puritan Medical Products Company Information
Table 115. Puritan Medical Products Business Overview
Table 116. Puritan Medical Products RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 117. Puritan Medical Products RNA Sample Preservation Solution Product Portfolio
Table 118. Puritan Medical Products Recent Development
Table 119. Beijing Hanbaihan Medical Company Information
Table 120. Beijing Hanbaihan Medical Business Overview
Table 121. Beijing Hanbaihan Medical RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 122. Beijing Hanbaihan Medical RNA Sample Preservation Solution Product Portfolio
Table 123. Beijing Hanbaihan Medical Recent Development
Table 124. Darui Biotech Company Information
Table 125. Darui Biotech Business Overview
Table 126. Darui Biotech RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 127. Darui Biotech RNA Sample Preservation Solution Product Portfolio
Table 128. Darui Biotech Recent Development
Table 129. Orient Gene Company Information
Table 130. Orient Gene Business Overview
Table 131. Orient Gene RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 132. Orient Gene RNA Sample Preservation Solution Product Portfolio
Table 133. Orient Gene Recent Development
Table 134. Biocomma Company Information
Table 135. Biocomma Business Overview
Table 136. Biocomma RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 137. Biocomma RNA Sample Preservation Solution Product Portfolio
Table 138. Biocomma Recent Development
Table 139. Guangdong Hybribio Biotech Company Information
Table 140. Guangdong Hybribio Biotech Business Overview
Table 141. Guangdong Hybribio Biotech RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 142. Guangdong Hybribio Biotech RNA Sample Preservation Solution Product Portfolio
Table 143. Guangdong Hybribio Biotech Recent Development
Table 144. Longsee Biomedical Company Information
Table 145. Longsee Biomedical Business Overview
Table 146. Longsee Biomedical RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 147. Longsee Biomedical RNA Sample Preservation Solution Product Portfolio
Table 148. Longsee Biomedical Recent Development
Table 149. Haimen Shengbang Laboratory Equipment Company Information
Table 150. Haimen Shengbang Laboratory Equipment Business Overview
Table 151. Haimen Shengbang Laboratory Equipment RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 152. Haimen Shengbang Laboratory Equipment RNA Sample Preservation Solution Product Portfolio
Table 153. Haimen Shengbang Laboratory Equipment Recent Development
Table 154. Hangzhou Jiuyang Biotechnology Company Information
Table 155. Hangzhou Jiuyang Biotechnology Business Overview
Table 156. Hangzhou Jiuyang Biotechnology RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 157. Hangzhou Jiuyang Biotechnology RNA Sample Preservation Solution Product Portfolio
Table 158. Hangzhou Jiuyang Biotechnology Recent Development
Table 159. Hangzhou LifeReal Biotechnology Company Information
Table 160. Hangzhou LifeReal Biotechnology Business Overview
Table 161. Hangzhou LifeReal Biotechnology RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 162. Hangzhou LifeReal Biotechnology RNA Sample Preservation Solution Product Portfolio
Table 163. Hangzhou LifeReal Biotechnology Recent Development
Table 164. Jifan Biotechnology (Beijing) Company Information
Table 165. Jifan Biotechnology (Beijing) Business Overview
Table 166. Jifan Biotechnology (Beijing) RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 167. Jifan Biotechnology (Beijing) RNA Sample Preservation Solution Product Portfolio
Table 168. Jifan Biotechnology (Beijing) Recent Development
Table 169. Mole Bioscience Company Information
Table 170. Mole Bioscience Business Overview
Table 171. Mole Bioscience RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 172. Mole Bioscience RNA Sample Preservation Solution Product Portfolio
Table 173. Mole Bioscience Recent Development
Table 174. Thermo Fisher Scientific Company Information
Table 175. Thermo Fisher Scientific Business Overview
Table 176. Thermo Fisher Scientific RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 177. Thermo Fisher Scientific RNA Sample Preservation Solution Product Portfolio
Table 178. Thermo Fisher Scientific Recent Development
Table 179. Shandong Chengwu Medical Products Factory Company Information
Table 180. Shandong Chengwu Medical Products Factory Business Overview
Table 181. Shandong Chengwu Medical Products Factory RNA Sample Preservation Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 182. Shandong Chengwu Medical Products Factory RNA Sample Preservation Solution Product Portfolio
Table 183. Shandong Chengwu Medical Products Factory Recent Development
Table 184. Key Raw Materials
Table 185. Raw Materials Key Suppliers
Table 186. RNA Sample Preservation Solution Distributors List
Table 187. RNA Sample Preservation Solution Customers List
Table 188. Research Programs/Design for This Report
Table 189. Authors List of This Report
Table 190. Secondary Sources
Table 191. Primary Sources
List of Figures
Figure 1. RNA Sample Preservation Solution Product Image
Figure 2. Global RNA Sample Preservation Solution Sales Value (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global RNA Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 4. Global RNA Sample Preservation Solution Sales (2021-2032) & (k units)
Figure 5. Global RNA Sample Preservation Solution Sales Average Price (USD/unit) & (2021-2032)
Figure 6. Global RNA Sample Preservation Solution Company Revenue Ranking in 2025 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 9. Inactivated Image
Figure 10. Non-inactivated Image
Figure 11. Global RNA Sample Preservation Solution Sales Volume by Type (2021 VS 2025 VS 2032) & (k units)
Figure 12. Global RNA Sample Preservation Solution Sales Volume Share 2021 VS 2025 VS 2032
Figure 13. Global RNA Sample Preservation Solution Sales Volume Share by Type (2021-2032)
Figure 14. Global RNA Sample Preservation Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 15. Global RNA Sample Preservation Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 16. Global RNA Sample Preservation Solution Sales Value Share by Type (2021-2032)
Figure 17. Hospital Image
Figure 18. Clinic Image
Figure 19. Others Image
Figure 20. Global RNA Sample Preservation Solution Sales Volume by Application (2021 VS 2025 VS 2032) & (k units)
Figure 21. Global RNA Sample Preservation Solution Sales Volume Share 2021 VS 2025 VS 2032
Figure 22. Global RNA Sample Preservation Solution Sales Volume Share by Application (2021-2032)
Figure 23. Global RNA Sample Preservation Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 24. Global RNA Sample Preservation Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 25. Global RNA Sample Preservation Solution Sales Value Share by Application (2021-2032)
Figure 26. Global RNA Sample Preservation Solution Sales by Region: 2021 VS 2025 VS 2032 (k units)
Figure 27. Global RNA Sample Preservation Solution Sales Market Share by Region: 2021 VS 2025 VS 2032
Figure 28. Global RNA Sample Preservation Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 29. Global RNA Sample Preservation Solution Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 30. North America RNA Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 31. North America RNA Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 32. Europe RNA Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 33. Europe RNA Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 34. Asia-Pacific RNA Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 35. Asia-Pacific RNA Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 36. South America RNA Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 37. South America RNA Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 38. Middle East & Africa RNA Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 39. Middle East & Africa RNA Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 40. USA RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. USA RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. USA RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. Canada RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. Canada RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. Canada RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. Mexico RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. Mexico RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. Mexico RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Germany RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Germany RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Germany RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. France RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. France RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. France RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. U.K. RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. U.K. RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. U.K. RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Italy RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Italy RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Italy RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Spain RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Spain RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Spain RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. Russia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. Russia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. Russia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Netherlands RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Netherlands RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Netherlands RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. Nordic Countries RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. Nordic Countries RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. Nordic Countries RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. China RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. China RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. China RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Japan RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Japan RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Japan RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. South Korea RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. South Korea RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. South Korea RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. India RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. India RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. India RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Australia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Australia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Australia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Southeast Asia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Southeast Asia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Southeast Asia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Brazil RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Brazil RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Brazil RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Argentina RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Argentina RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Argentina RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Chile RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Chile RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Chile RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Colombia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Colombia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Colombia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. Peru RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. Peru RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. Peru RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Saudi Arabia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Saudi Arabia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Saudi Arabia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Israel RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Israel Arabia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Israel Arabia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. UAE RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. UAE RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. UAE RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Turkey RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 116. Turkey RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 117. Turkey RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 118. Iran RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 119. Iran RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 120. Iran RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 121. Egypt RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 122. Egypt RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 123. Egypt RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 124. RNA Sample Preservation Solution Value Chain
Figure 125. Manufacturing Cost Structure
Figure 126. RNA Sample Preservation Solution Sales Mode & Process
Figure 127. Direct Comparison with Distribution Share
Figure 128. Distributors Profiles
Figure 129. Years Considered
Figure 130. Research Process
Figure 131. Key Executives Interviewed
Scope & coverage.
Types
- Inactivated
- Non-inactivated
Applications
- Hospital
- Clinic
- Others
Companies covered
- Aptaca
- BD
- BIOBASE
- BioServUK
- Biosigma
- Cardinal Health
- Copan Diagnostics
- EKF Diagnostics Holdings
- Longhorn Vaccines and Diagnostics
- Medline Industries
- Puritan Medical Products
- Beijing Hanbaihan Medical
- Darui Biotech
- Orient Gene
- Biocomma
- Guangdong Hybribio Biotech
- Longsee Biomedical
- Haimen Shengbang Laboratory Equipment
- Hangzhou Jiuyang Biotechnology
- Hangzhou LifeReal Biotechnology
- Jifan Biotechnology (Beijing)
- Mole Bioscience
- Thermo Fisher Scientific
- Shandong Chengwu Medical Products Factory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global RNA Sample Preservation Solution Sales Value (2021-2032)
- 1.2.2 Global RNA Sample Preservation Solution Sales Volume (2021-2032)
- 1.2.3 Global RNA Sample Preservation Solution Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 RNA Sample Preservation Solution Market Dynamics
- 2.1 RNA Sample Preservation Solution Industry Trends
- 2.2 RNA Sample Preservation Solution Industry Drivers
- 2.3 RNA Sample Preservation Solution Industry Opportunities and Challenges
- 2.4 RNA Sample Preservation Solution Industry Restraints
3 RNA Sample Preservation Solution Market by Company
- 3.1 Global RNA Sample Preservation Solution Company Revenue Ranking in 2025
- 3.2 Global RNA Sample Preservation Solution Revenue by Company (2021-2026)
- 3.3 Global RNA Sample Preservation Solution Sales Volume by Company (2021-2026)
- 3.4 Global RNA Sample Preservation Solution Average Price by Company (2021-2026)
- 3.5 Global RNA Sample Preservation Solution Company Ranking (2024-2026)
- 3.6 Global RNA Sample Preservation Solution Company Manufacturing Base and Headquarters
- 3.7 Global RNA Sample Preservation Solution Company Product Type and Application
- 3.8 Global RNA Sample Preservation Solution Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global RNA Sample Preservation Solution Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 RNA Sample Preservation Solution Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 RNA Sample Preservation Solution Market by Type
- 4.1 RNA Sample Preservation Solution Type Introduction
- 4.1.1 Inactivated
- 4.1.2 Non-inactivated
- 4.2 Global RNA Sample Preservation Solution Sales Volume by Type
- 4.2.1 Global RNA Sample Preservation Solution Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global RNA Sample Preservation Solution Sales Volume by Type (2021-2032)
- 4.2.3 Global RNA Sample Preservation Solution Sales Volume Share by Type (2021-2032)
- 4.3 Global RNA Sample Preservation Solution Sales Value by Type
- 4.3.1 Global RNA Sample Preservation Solution Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global RNA Sample Preservation Solution Sales Value by Type (2021-2032)
- 4.3.3 Global RNA Sample Preservation Solution Sales Value Share by Type (2021-2032)
5 RNA Sample Preservation Solution Market by Application
- 5.1 RNA Sample Preservation Solution Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global RNA Sample Preservation Solution Sales Volume by Application
- 5.2.1 Global RNA Sample Preservation Solution Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global RNA Sample Preservation Solution Sales Volume by Application (2021-2032)
- 5.2.3 Global RNA Sample Preservation Solution Sales Volume Share by Application (2021-2032)
- 5.3 Global RNA Sample Preservation Solution Sales Value by Application
- 5.3.1 Global RNA Sample Preservation Solution Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global RNA Sample Preservation Solution Sales Value by Application (2021-2032)
- 5.3.3 Global RNA Sample Preservation Solution Sales Value Share by Application (2021-2032)
6 RNA Sample Preservation Solution Regional Sales and Value Analysis
- 6.1 Global RNA Sample Preservation Solution Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global RNA Sample Preservation Solution Sales by Region (2021-2032)
- 6.2.1 Global RNA Sample Preservation Solution Sales by Region: 2021-2026
- 6.2.2 Global RNA Sample Preservation Solution Sales by Region (2027-2032)
- 6.3 Global RNA Sample Preservation Solution Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global RNA Sample Preservation Solution Sales Value by Region (2021-2032)
- 6.4.1 Global RNA Sample Preservation Solution Sales Value by Region: 2021-2026
- 6.4.2 Global RNA Sample Preservation Solution Sales Value by Region (2027-2032)
- 6.5 Global RNA Sample Preservation Solution Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America RNA Sample Preservation Solution Sales Value (2021-2032)
- 6.6.2 North America RNA Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe RNA Sample Preservation Solution Sales Value (2021-2032)
- 6.7.2 Europe RNA Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific RNA Sample Preservation Solution Sales Value (2021-2032)
- 6.8.2 Asia-Pacific RNA Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America RNA Sample Preservation Solution Sales Value (2021-2032)
- 6.9.2 South America RNA Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa RNA Sample Preservation Solution Sales Value (2021-2032)
- 6.10.2 Middle East & Africa RNA Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
7 RNA Sample Preservation Solution Country-level Sales and Value Analysis
- 7.1 Global RNA Sample Preservation Solution Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global RNA Sample Preservation Solution Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global RNA Sample Preservation Solution Sales by Country (2021-2032)
- 7.3.1 Global RNA Sample Preservation Solution Sales by Country (2021-2026)
- 7.3.2 Global RNA Sample Preservation Solution Sales by Country (2027-2032)
- 7.4 Global RNA Sample Preservation Solution Sales Value by Country (2021-2032)
- 7.4.1 Global RNA Sample Preservation Solution Sales Value by Country (2021-2026)
- 7.4.2 Global RNA Sample Preservation Solution Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.5.2 USA RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.9.2 France RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.16.2 China RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.19.2 India RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt RNA Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt RNA Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt RNA Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Aptaca
- 8.1.1 Aptaca Company Information
- 8.1.2 Aptaca Business Overview
- 8.1.3 Aptaca RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Aptaca RNA Sample Preservation Solution Product Portfolio
- 8.1.5 Aptaca Recent Developments
- 8.2 BD
- 8.2.1 BD Company Information
- 8.2.2 BD Business Overview
- 8.2.3 BD RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.2.4 BD RNA Sample Preservation Solution Product Portfolio
- 8.2.5 BD Recent Developments
- 8.3 BIOBASE
- 8.3.1 BIOBASE Company Information
- 8.3.2 BIOBASE Business Overview
- 8.3.3 BIOBASE RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.3.4 BIOBASE RNA Sample Preservation Solution Product Portfolio
- 8.3.5 BIOBASE Recent Developments
- 8.4 BioServUK
- 8.4.1 BioServUK Company Information
- 8.4.2 BioServUK Business Overview
- 8.4.3 BioServUK RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.4.4 BioServUK RNA Sample Preservation Solution Product Portfolio
- 8.4.5 BioServUK Recent Developments
- 8.5 Biosigma
- 8.5.1 Biosigma Company Information
- 8.5.2 Biosigma Business Overview
- 8.5.3 Biosigma RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Biosigma RNA Sample Preservation Solution Product Portfolio
- 8.5.5 Biosigma Recent Developments
- 8.6 Cardinal Health
- 8.6.1 Cardinal Health Company Information
- 8.6.2 Cardinal Health Business Overview
- 8.6.3 Cardinal Health RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Cardinal Health RNA Sample Preservation Solution Product Portfolio
- 8.6.5 Cardinal Health Recent Developments
- 8.7 Copan Diagnostics
- 8.7.1 Copan Diagnostics Company Information
- 8.7.2 Copan Diagnostics Business Overview
- 8.7.3 Copan Diagnostics RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Copan Diagnostics RNA Sample Preservation Solution Product Portfolio
- 8.7.5 Copan Diagnostics Recent Developments
- 8.8 EKF Diagnostics Holdings
- 8.8.1 EKF Diagnostics Holdings Company Information
- 8.8.2 EKF Diagnostics Holdings Business Overview
- 8.8.3 EKF Diagnostics Holdings RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.8.4 EKF Diagnostics Holdings RNA Sample Preservation Solution Product Portfolio
- 8.8.5 EKF Diagnostics Holdings Recent Developments
- 8.9 Longhorn Vaccines and Diagnostics
- 8.9.1 Longhorn Vaccines and Diagnostics Company Information
- 8.9.2 Longhorn Vaccines and Diagnostics Business Overview
- 8.9.3 Longhorn Vaccines and Diagnostics RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Longhorn Vaccines and Diagnostics RNA Sample Preservation Solution Product Portfolio
- 8.9.5 Longhorn Vaccines and Diagnostics Recent Developments
- 8.10 Medline Industries
- 8.10.1 Medline Industries Company Information
- 8.10.2 Medline Industries Business Overview
- 8.10.3 Medline Industries RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Medline Industries RNA Sample Preservation Solution Product Portfolio
- 8.10.5 Medline Industries Recent Developments
- 8.11 Puritan Medical Products
- 8.11.1 Puritan Medical Products Company Information
- 8.11.2 Puritan Medical Products Business Overview
- 8.11.3 Puritan Medical Products RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Puritan Medical Products RNA Sample Preservation Solution Product Portfolio
- 8.11.5 Puritan Medical Products Recent Developments
- 8.12 Beijing Hanbaihan Medical
- 8.12.1 Beijing Hanbaihan Medical Company Information
- 8.12.2 Beijing Hanbaihan Medical Business Overview
- 8.12.3 Beijing Hanbaihan Medical RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Beijing Hanbaihan Medical RNA Sample Preservation Solution Product Portfolio
- 8.12.5 Beijing Hanbaihan Medical Recent Developments
- 8.13 Darui Biotech
- 8.13.1 Darui Biotech Company Information
- 8.13.2 Darui Biotech Business Overview
- 8.13.3 Darui Biotech RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Darui Biotech RNA Sample Preservation Solution Product Portfolio
- 8.13.5 Darui Biotech Recent Developments
- 8.14 Orient Gene
- 8.14.1 Orient Gene Company Information
- 8.14.2 Orient Gene Business Overview
- 8.14.3 Orient Gene RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Orient Gene RNA Sample Preservation Solution Product Portfolio
- 8.14.5 Orient Gene Recent Developments
- 8.15 Biocomma
- 8.15.1 Biocomma Company Information
- 8.15.2 Biocomma Business Overview
- 8.15.3 Biocomma RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Biocomma RNA Sample Preservation Solution Product Portfolio
- 8.15.5 Biocomma Recent Developments
- 8.16 Guangdong Hybribio Biotech
- 8.16.1 Guangdong Hybribio Biotech Company Information
- 8.16.2 Guangdong Hybribio Biotech Business Overview
- 8.16.3 Guangdong Hybribio Biotech RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Guangdong Hybribio Biotech RNA Sample Preservation Solution Product Portfolio
- 8.16.5 Guangdong Hybribio Biotech Recent Developments
- 8.17 Longsee Biomedical
- 8.17.1 Longsee Biomedical Company Information
- 8.17.2 Longsee Biomedical Business Overview
- 8.17.3 Longsee Biomedical RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Longsee Biomedical RNA Sample Preservation Solution Product Portfolio
- 8.17.5 Longsee Biomedical Recent Developments
- 8.18 Haimen Shengbang Laboratory Equipment
- 8.18.1 Haimen Shengbang Laboratory Equipment Company Information
- 8.18.2 Haimen Shengbang Laboratory Equipment Business Overview
- 8.18.3 Haimen Shengbang Laboratory Equipment RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Haimen Shengbang Laboratory Equipment RNA Sample Preservation Solution Product Portfolio
- 8.18.5 Haimen Shengbang Laboratory Equipment Recent Developments
- 8.19 Hangzhou Jiuyang Biotechnology
- 8.19.1 Hangzhou Jiuyang Biotechnology Company Information
- 8.19.2 Hangzhou Jiuyang Biotechnology Business Overview
- 8.19.3 Hangzhou Jiuyang Biotechnology RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Hangzhou Jiuyang Biotechnology RNA Sample Preservation Solution Product Portfolio
- 8.19.5 Hangzhou Jiuyang Biotechnology Recent Developments
- 8.20 Hangzhou LifeReal Biotechnology
- 8.20.1 Hangzhou LifeReal Biotechnology Company Information
- 8.20.2 Hangzhou LifeReal Biotechnology Business Overview
- 8.20.3 Hangzhou LifeReal Biotechnology RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Hangzhou LifeReal Biotechnology RNA Sample Preservation Solution Product Portfolio
- 8.20.5 Hangzhou LifeReal Biotechnology Recent Developments
- 8.21 Jifan Biotechnology (Beijing)
- 8.21.1 Jifan Biotechnology (Beijing) Company Information
- 8.21.2 Jifan Biotechnology (Beijing) Business Overview
- 8.21.3 Jifan Biotechnology (Beijing) RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Jifan Biotechnology (Beijing) RNA Sample Preservation Solution Product Portfolio
- 8.21.5 Jifan Biotechnology (Beijing) Recent Developments
- 8.22 Mole Bioscience
- 8.22.1 Mole Bioscience Company Information
- 8.22.2 Mole Bioscience Business Overview
- 8.22.3 Mole Bioscience RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Mole Bioscience RNA Sample Preservation Solution Product Portfolio
- 8.22.5 Mole Bioscience Recent Developments
- 8.23 Thermo Fisher Scientific
- 8.23.1 Thermo Fisher Scientific Company Information
- 8.23.2 Thermo Fisher Scientific Business Overview
- 8.23.3 Thermo Fisher Scientific RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Thermo Fisher Scientific RNA Sample Preservation Solution Product Portfolio
- 8.23.5 Thermo Fisher Scientific Recent Developments
- 8.24 Shandong Chengwu Medical Products Factory
- 8.24.1 Shandong Chengwu Medical Products Factory Company Information
- 8.24.2 Shandong Chengwu Medical Products Factory Business Overview
- 8.24.3 Shandong Chengwu Medical Products Factory RNA Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Shandong Chengwu Medical Products Factory RNA Sample Preservation Solution Product Portfolio
- 8.24.5 Shandong Chengwu Medical Products Factory Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 RNA Sample Preservation Solution Value Chain Analysis
- 9.1.1 RNA Sample Preservation Solution Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 RNA Sample Preservation Solution Sales Mode & Process
- 9.2 RNA Sample Preservation Solution Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 RNA Sample Preservation Solution Distributors
- 9.2.3 RNA Sample Preservation Solution Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst